Par Drugs & Chemicals standalone net profit declines 0.41% in the March 2022 quarter

Sales rise 36.21% to Rs 22.08 crore

Net profit of Par Drugs & Chemicals declined 0.41% to Rs 2.42 crore in the quarter ended March 2022 as against Rs 2.43 crore during the previous quarter ended March 2021. Sales rose 36.21% to Rs 22.08 crore in the quarter ended March 2022 as against Rs 16.21 crore during the previous quarter ended March 2021.

For the full year,net profit declined 20.59% to Rs 9.22 crore in the year ended March 2022 as against Rs 11.61 crore during the previous year ended March 2021. Sales rose 23.57% to Rs 75.07 crore in the year ended March 2022 as against Rs 60.75 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales22.0816.21 36 75.0760.75 24 OPM %20.4326.59 -21.6626.34 - PBDT4.494.15 8 15.9915.55 3 PBT3.623.42 6 12.7112.73 0 NP2.422.43 0 9.2211.61 -21

Powered by Capital Market - Live News